So much to catch up on, on this thread; so much I'd like to respond to...I'll have to just pick out a couple of points...
This is the biggest mystery of our time, I think it is bigger than global warming.
I absolutely agree alex. Phrases like 'global pandemic' and 'biological weapon of mass destruction' have been used, and to anyone who's actually read about what we're dealing with here, that doesn't sound overblown to me at all. Unfortunately we have to remember that the vast majority of people have heard
nothing about any of this from their media, so we're in a difficult position as usual. If we tell it like it is, we look like complete nutters to most 'reasonable' people. To get any kind of sense of how such a massively significant phenomenon can be known to us and yet not be in the papers...explaining that takes a long time, individuals need a whole lot of information before they can be brought to that point. Very frustrating.
But anyway, I agree with many posters here who are talking about figures of up to 10%. A lot of people have been talking about their pet theories lately, and I think that's all good. So for me I'll restate once again that my strong feeling is that retrovirology will be the key linchpin to understanding MS, IBS, CFS, GWI, and a whole range of 'medically unexplained' phenomena. Anybody with neuro-immune problems who it turns out hasn't got XMRV, I would be looking for other retroviruses.
The point has been made that it is immune
dysregulation that we're talking about here. That seems right to me, and to fit with (for just one example) Gupta's amygdala training; Gerwyn has also confirmed some pieces of the puzzle relating to upregulation or downregulation of immune responses. Failure of
regulation of immune responses seems to me to be quite a key point to latch on to.
Tina: I enjoyed your posts, as always, but there's one para I disagree with:
i don't think this German study resolves anything but to say it is in Europe and is either higher in number or easier to find in immuno suppressed people. This doesn't say it happens in higher rates of CFSers. The previous studies, the three negative, I think some of them found the virus, but they didn't find it in CFSers or they didn't find it in higher rate in CFSers. If I remember right, I think one said they found it in a healthy person (just one) but didn't find it in any of the CFS samples. But the new German study doesn't dispute any of the three negative study results. The previous studies weren't saying XMRV isn't in Europe, they were saying it doesn't cause ME / CFS in Europe.
First UK study only looked at ME / CFS people. They found none.
I am sorry, too sick to remember or find the others.
Having followed the UK and Dutch studies in some detail at the time they came out, I don't think it is relevant that they only looked at ME/CFS people. We did a lot of analysis at the time, and the key point is this: none of those 3 studies found any XMRV at all. You're right that Kerr's study mentioned it may have found one or two possible positives in one batch, but they then backtracked and said they could actually be something different anyway. (It was a bit weird, because they effectively said it turns out that with their test, even their handful of positives aren't necessarily positives, but there you go!).
We crunched the numbers and considered the angles, and the firm conclusion was: the only way they could all get 0% (remembering that Kerr's study tested on a lot of samples) was if there was either no XMRV in the UK, or if their tests weren't good enough.
The detailed inadequacy of the testing methodology has been identified by Gerwyn and others, and it turns out that the people who
are finding XMRV are using the right procedures that one would expect to be more likely to work. It's turning out to be a lot harder to detect XMRV than expected, which has confounded things quite a bit.
So anyway: given that the Germans have now found a background level of 3% or so, consistent with US and Japanese findings, the probability of the UK studies testing hundreds of samples - ME/CFS or otherwise - and finding no XMRV, is infinitesimally small.
If 3% of the population have XMRV, then at least 3% of ME/CFS patients should have it. Even if it's not associated with ME/CFS, they should still have found some XMRV in some of the samples. Even at 3%, with a few hundred samples, the chances of finding none at all are very, very small.
McClure actually did try to suggest, in the press, that there might be no XMRV in Europe at all. They won't take samples from the WPI on the basis that they're afraid of introducing XMRV to Europe by doing so. So actually, that quite ludicrous proposition is what has been suggested, and that's why it's so important that the German study has debunked it.
The only way you could hold out any other interpretation of the failed UK studies - other than that they simply failed as in
FAIL - would be to suggest that ME/CFS patients, for some reason, uniquely have
no XMRV - ie we're resistant to it somehow. Just not credible given what WPI found in the first place.
Of course, what you said is exactly what the Wessely school and the cautious scientific world will continue to say; they will continue to urge caution as always, and they will say that ME/CFS association with XMRV remains unproven in Europe. Even after there have been studies that do find that association in Europe, I'm sure they will produce further negative studies and then do studies of studies that attempt to balance it all out and make a case that the association is 'unproven'. My expectation is that as the game draws to a close, they will make themselves look more and more foolish and come out with some truly ridiculous stuff that exposes their whole modus operandi. They will carry on, on auto-pilot, right up until they crash into the cliff. So every little step will have to be made one by one, and until it's all conclusively proven, nobody will be allowed to believe anything.
Won't stop me believing though...:Retro smile: